High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-I

Transgenic Research

Volumn 1, Issue 3, 1992, Pages 142-147

  Swanson, Marke E ^a   Hughes, Thomas E ^a   Denny, Irene St ^a   France, Dennis S ^a   Paterniti Jr , James R ^a   Tapparelli, Carlo ^b   Gfeller, Patrick ^b   Bürki, Kurt ^b  

^a Sandoz Pharma Ltd   (Switzerland)

^b Preclinical Research   (Switzerland)

Author keywords

apolipoprotein A I; HDL; rat; transgenic

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; MESSENGER RNA; PHOSPHOLIPID;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BIOSYNTHESIS; BLOOD; FEMALE; GENE EXPRESSION; GENETICS; HOMOZYGOTE; HUMAN; MALE; METABOLISM; RAT; RAT STRAIN; RESTRICTION MAPPING; TRANSGENIC ANIMAL; WESTERN BLOTTING;

ANIMAL; ANIMALS, GENETICALLY MODIFIED; APOLIPOPROTEIN A-I; BLOTTING, WESTERN; CHOLESTEROL; FEMALE; GENE EXPRESSION; HOMOZYGOTE; HUMAN; LIPOPROTEINS; LIPOPROTEINS, HDL CHOLESTEROL; MALE; ORGAN SPECIFICITY; PHOSPHOLIPIDS; RATS; RATS, INBRED STRAINS; RESTRICTION MAPPING; RNA, MESSENGER;

EID: 0026864920     PISSN: 09628819     EISSN: 15739368     Source Type: Journal    
DOI: 10.1007/BF02528779     Document Type: Article

References (26)

1. Culture of mouse embryos in vitro
2. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Heart Study
3. Identification of an enhancer-like element in the 5′ flanking region of the rat apolipoprotein A-I gene
4. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
5. Nonimmunochemical quantitation of mammalian apolipoprotein A-I in whole serum or plasma by non-reducing gel electrophoresis
6. Clinical chemistry applications of microplate robotic systems in a lipoprotein laboratory
7. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia
8. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study
9. High-density lipoprotein cholesterol and cardiovascular disease
10. Tissue-specific expression of apolipoprotein A-I (apoA-I) is regulated by the 5′-flanking region of the human apoA-I gene
11. Regulation of intestinal apolipoprotein B synthesis and secretion by Caco-2 cells
12. Hypertriglyceridemia as a result of human apo C-III gene expression in transgenic mice
13. Isolation and characterization of the human apolipoprotein A-I gene
14. Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease
15. Plasma high density lipoprotein concentration and development of ischemic heart disease
16. The Tromso Heart-Study. High-density lipoprotein and coronary heart-disease: a prospective case-control study
17. Intestinal expression of human apoA-I and apoC-III in transgenic mice
18. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts
19. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses
20. Different cis-acting DNA elements control expression of the human apolipoprotein A-I gene in different cell types
21. Detection of specific sequences among DNA fragments separated by gel electrophoresis
22. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3
23. Rapid bacteriophage sedimentation in the presence of polyethylene glycol and its application to large-scale virus purification